Ronald C Kennedy
Overview
Explore the profile of Ronald C Kennedy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aldrich J, Shearer M, Lowe D, Winn R, Jumper C, Kennedy R, et al.
Cancer Immunol Immunother
. 2012 Aug;
62(2):371-82.
PMID: 22926061
The central role of CD4+ T lymphocytes in mediating DNA vaccine-induced tumor immunity against the viral oncoprotein simian virus 40 (SV40) large tumor antigen (Tag) has previously been described by...
2.
Ahmad G, Zhang W, Torben W, Ahrorov A, Damian R, Wolf R, et al.
J Infect Dis
. 2011 Sep;
204(9):1437-49.
PMID: 21921206
The prophylactic efficacy of a schistosome antigen (Sm-p80) was tested in a nonhuman primate model, the baboon. Using a total of 28 baboons, different vaccination strategies were used including recombinant...
3.
Aldrich J, Lowe D, Shearer M, Winn R, Jumper C, Bright R, et al.
J Virol
. 2011 May;
85(14):7216-24.
PMID: 21593176
A mechanistic analysis of tumor immunity directed toward the viral oncoprotein simian virus 40 (SV40) large tumor antigen (Tag) has previously been described by our laboratory for scenarios of recombinant...
4.
Aldrich J, Lowe D, Shearer M, Winn R, Jumper C, Kennedy R
Clin Dev Immunol
. 2010 Oct;
2010:697158.
PMID: 20936120
The employment of the immune system to treat malignant disease represents an active area of biomedical research. The specificity of the immune response and potential for establishing long-term tumor immunity...
5.
Lowe D, Shearer M, Aldrich J, Winn R, Jumper C, Kennedy R
J Virol
. 2010 Jul;
84(19):10121-30.
PMID: 20668083
We examined properties of the innate immune response against the tumor-specific antigen simian virus 40 (SV40) large tumor antigen (Tag) following experimental pulmonary metastasis in naive mice. Approximately 14 days...
6.
Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian R, et al.
J Infect Dis
. 2010 Mar;
201(7):1105-12.
PMID: 20187746
To date, no vaccine is available to prevent human schistosomiasis. We have targeted a protein of Schistosoma mansoni that plays an important role in the surface membrane renewal process, a...
7.
Lowe D, Shearer M, Jumper C, Bright R, Kennedy R
J Virol
. 2009 Nov;
84(2):883-93.
PMID: 19889780
The required activities of CD4(+) T cells and antibody against the virally encoded oncoprotein simian virus 40 (SV40) Tag have previously been demonstrated by our laboratory to be mediators in...
8.
Ahmad G, Zhang W, Torben W, Damian R, Wolf R, White G, et al.
Vaccine
. 2009 Apr;
27(21):2830-7.
PMID: 19366570
Schistosomiasis is an important parasitic disease for which there is no available vaccine. We have focused on a functionally important antigen of Schistosoma mansoni, Sm-p80, as a vaccine candidate because...
9.
Chiriva-Internati M, Weidanz J, Yu Y, Frezza E, Jenkins M, Kennedy R, et al.
J Immunother
. 2008 Sep;
31(8):693-703.
PMID: 18779750
For ovarian cancer (OC) patients with advanced or metastatic disease, standard treatments (chemotherapy and radiotherapy) are not very effective and have undesirable side effects. Newer and more promising approaches in...
10.
Westfall L, Shearer M, Jumper C, White G, Papin J, Eberle R, et al.
Virology
. 2008 May;
377(1):54-62.
PMID: 18485439
Simian virus 40 (SV40) is a polyomavirus for which non-human primates are the permissive host. The baboon (Papio spp.) is an old world monkey that is used in a variety...